HUTCHMED (China) (HUTCHMED (China)) Construction In Progress : $8.4 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Construction In Progress?

HUTCHMED (China)'s quarterly construction in progress declined from Dec. 2022 ($54.6 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($8.4 Mil).

HUTCHMED (China)'s annual construction in progress increased from Dec. 2021 ($20.0 Mil) to Dec. 2022 ($54.6 Mil) but then declined from Dec. 2022 ($54.6 Mil) to Dec. 2023 ($8.4 Mil).

HUTCHMED (China) Construction In Progress Historical Data

The historical data trend for HUTCHMED (China)'s Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Construction In Progress Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

0.93

3.05

19.97

54.55

8.42

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Construction In Progress	Get a 7-Day Free Trial															19.97	-	54.55	-	8.42

HUTCHMED (China) Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.